Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury — Bruno Garcia (2024) | RDL Network
Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury
Article 2024 en
Authors
BG
Bruno Garcia
BS
Benoit Ter Schiphorst
KS
Karine Santos
Abstract
1 min read
In an experimental model of septic shock, PCZ administration was associated with reduced fluid and catecholamine requirements, less myocardial injury and cardiovascular inflammation, along with preserved angiotensin II signaling.
Bruno Garcia, Fuhong Su, Laurence Dewachter, Raphaël Favory, Amina Khaldi, Alexander Moiroux-Sahraoui, Filippo Annoni, Francisco Vasques‐Nóvoa, Estela Rocha-Oliveira, Roberto Roncon‐Albuquerque, Géraldine Hubesch, Hassane Njimi, Jean Louis Vincent, Fabio Silvio Taccone, Jacques Créteur, Antoine Herpain
Bruno Garcia, Fuhong Su, Laurence Dewachter, Yong Wang, Ning Li, Myriam Remmelink, Marie Van Eycken, Amina Khaldi, Raphaël Favory, Antoine Herpain, Anthony Moreau, Alexander Moiroux-Sahraoui, Francesca Manicone, Filippo Annoni, Lin Shi, Jean Louis Vincent, Jacques Créteur, Fabio Silvio Taccone
Diamantino Salgado, Xinrong He, Fuhong Su, Dalton Barros de Sousa, Laura Penaccini, Leonardo Kfuri Maciel, Fabio Silvio Taccone, José Rodolfo Rocco, Eliézer Silva, Daniel De Backer, Jean Louis Vincent
Discussion(0)
No comments yet. Be the first to comment.